financetom
Business
financetom
/
Business
/
Africa Energy Receives Extension to Deadline for Submission of ESIA in Relation to Block 11B/12B
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Africa Energy Receives Extension to Deadline for Submission of ESIA in Relation to Block 11B/12B
Oct 10, 2025 4:42 AM

07:11 AM EDT, 10/10/2025 (MT Newswires) -- Africa Energy ( HPMCF ) overnight Thursday said through its investment in Main Street 1549, which holds a 10% participating interest in Block 11B / 12B, offshore the Republic of South Africa, it has obtained an extension to the deadline for the submission of a new Environmental and Social Impact Assessment (ESIA) to May 4, 2026.

The company said the extension to the ESIA has been granted in light of the recent decision by the Western Cape High Court in South Africa to set aside an environmental authorization for offshore exploration operations in Block 5/6/7 held by an unrelated party, so that additional, new and amended environmental assessments can be conducted and placed before the Minister of Mineral and Petroleum Resources for reconsideration. It said that an application for leave to appeal this decision to the Supreme Court of Appeal has been launched by the unrelated party.

The grant of the environmental authorization is a pre-requisite to the grant of the production right in relation to Block 11B/12B, therefore, the company said it is continuing to gather information and work with applicable regulators in order to better understand the current situation.

Shares of the company closed unchanged at $0.16 Thursday on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
DocGo Expands Partnership With SHL Telemedicine to Enhance Cardiovascular Care
DocGo Expands Partnership With SHL Telemedicine to Enhance Cardiovascular Care
Dec 18, 2024
08:48 AM EST, 12/18/2024 (MT Newswires) -- DocGo ( DCGO ) said Wednesday it expanded its partnership with SHL Telemedicine ( SHLT ) to integrate the SmartHeart portable 12-lead ECG device into its mobile healthcare units. Initially launched in the New York-New Jersey area, the company said the collaboration will extend advanced cardiovascular diagnostics to patients' homes and underserved communities...
Oil Falls on Larger-Than-Expected Drop in U.S. Inventories Ahead of Fed's Interest-Rate Decision
Oil Falls on Larger-Than-Expected Drop in U.S. Inventories Ahead of Fed's Interest-Rate Decision
Dec 18, 2024
08:51 AM EST, 12/18/2024 (MT Newswires) -- Oil traded higher early on Wednesday after a report showed U.S. oil inventories fell by more than expected last week, while a third straight cut to U.S. interest rates from the Federal Reserve is awaited. West Texas Intermediate crude for January delivery was last seen up US$0.72 to US$70.80 per barrel, while February...
Coeur Mining Says Silvertip Exploration Program Doubles Strike Length of Southern Silver Zone Mineralization
Coeur Mining Says Silvertip Exploration Program Doubles Strike Length of Southern Silver Zone Mineralization
Dec 18, 2024
08:51 AM EST, 12/18/2024 (MT Newswires) -- Coeur Mining ( CDE ) said Wednesday that the initial results of its 2024 exploration program at its Silvertip project in northern British Columbia showed that it doubled the strike length of the Southern Silver Zone mineralization. Fieldwork also identified three high-priority targets that showed similarities to Silvertip, a polymetallic critical minerals exploration...
Cognition Therapeutics Says Study of Drug to Treat Lewy Body Dementia Meets Primary Endpoint; Shares Jump
Cognition Therapeutics Says Study of Drug to Treat Lewy Body Dementia Meets Primary Endpoint; Shares Jump
Dec 18, 2024
08:49 AM EST, 12/18/2024 (MT Newswires) -- Cognition Therapeutics ( CGTX ) said Wednesday that a phase 2 study of CT1812 to treat patients with Lewy body dementia met its primary endpoint of safety and tolerability. The drug produced strong therapeutic responses across behavioral, functional, cognitive and movement measures in patients who received the treatment for six months, compared to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved